Question 1

Am I eligible for this trial based on my treatment history?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer clinical trial (NCT00057720). Contact the study team or your healthcare provider for specific answers.

Question 2

How does TLK286 compare to my current treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer clinical trial (NCT00057720). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I expect from TLK286?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer clinical trial (NCT00057720). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for treatment and check-ups?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer clinical trial (NCT00057720). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if my cancer progresses while in the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer clinical trial (NCT00057720). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any additional tests or procedures involved in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer clinical trial (NCT00057720). Contact the study team or your healthcare provider for specific answers.

What this study is about